Kiadis names new CMO
This article was originally published in Scrip
Executive Summary
Kiadis Pharma, a clinical-stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, has appointed Dr Jeroen Rovers chief medical officer. Most recently Dr Rovers was CMO at Ceronco Biosciences; though he was previously vice-president of medical affairs at Kiadis, and remained a consultant to the company until his re-appointment as CMO.